Neurocognitive Impairment and Its Long-term Impact on Adults With Congenital Heart Disease

Scott Cohen1, Michael G Earing1

  • 1Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, United States of America; Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, United States of America.

Insights

Adult survivors with congenital heart disease (ACHD) often experience cognitive dysfunction, impacting quality of life. Understanding and addressing this under-recognized issue may improve long-term outcomes for ACHD patients.

Area of Science:

  • Cardiology
  • Neuroscience
  • Public Health

Background:

  • Adult survivors with congenital heart disease (ACHD) face risks of non-cardiac comorbidities.
  • Cognitive dysfunction is a prevalent yet under-recognized complication in ACHD.
  • Impaired cognition significantly affects quality of life, including social and professional aspects.

Purpose of the Study:

  • To review the current understanding of cognitive dysfunction in ACHD.
  • To explore the prevalence, impact, and management strategies for cognitive dysfunction in ACHD.
  • To highlight the need for further research and intervention in this area.

Main Methods:

  • Literature review of studies on cognitive function in adult congenital heart disease survivors.
  • Synthesis of data on prevalence, clinical impact, and management approaches.
  • Analysis of the association between cognitive dysfunction and quality of life in ACHD.

Main Results:

  • Cognitive dysfunction is common in ACHD and significantly impacts daily living.
  • The full scope of cognitive dysfunction's impact on ACHD morbidity is not well understood.
  • Cognitive dysfunction represents a potentially modifiable risk factor in ACHD.

Conclusions:

  • Cognitive dysfunction is a critical, understudied issue in ACHD survivors.
  • Interventions targeting cognitive dysfunction may improve outcomes for ACHD patients.
  • Further research is essential to fully understand and manage cognitive dysfunction in ACHD.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment01:08

Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment

Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
534
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.4K
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
368
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
340
Impact of Groups on Groups01:19

Impact of Groups on Groups

Social psychologists analyze how groups influence one another, shaping social structures and interactions through both cooperation and competition. These dynamics manifest in various ways, ranging from economic partnerships to intergroup conflicts that shape societal structures and perceptions.Cooperation and Competition in Intergroup RelationsIntergroup relationships vary across contexts, sometimes fostering cooperation and mutual benefit while at other times leading to conflict and...
251